Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis

Inflammatory Bowel Diseases

Volumn 16, Issue 8, 2010, Pages 1352-1356

  Pekow, Joel R ^a   Hetzel, Jeremy T ^a   Rothe, Jami A ^a   Hanauer, Stephen B ^a   Turner, Jerrold R ^a   Hart, John ^a   Noffsinger, Amy ^a   Huo, Dezheng ^a   Rubin, David T ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Colorectal cancer; Dysplasia; Ulcerative colitis

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; COLORECTAL CANCER; DISEASE COURSE; DISEASE SURVEILLANCE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; HAZARD RATIO; HUMAN; INCIDENCE; INDEFINITE DYSPLASIA; LOW GRADE DYSPLASIA; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS;

ADENOCARCINOMA; ADOLESCENT; ADULT; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGITIS, SCLEROSING; COLECTOMY; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; INCIDENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SENTINEL SURVEILLANCE; YOUNG ADULT;

EID: 77955747991     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21184     Document Type: Article

References (22)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535. (Pubitemid 32234798)
2. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228-1233. (Pubitemid 20366527)
3. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356-1362. (Pubitemid 32322309)
4. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:1643-1649. (Pubitemid 29260459)
5. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711-714. (Pubitemid 28261062)
6. Lashneer BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis. Am J Gastroenterol. 1995;95:1083-1087.
7. Choi PM, Nugent FW, Schoetz DJ, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418-424. (Pubitemid 23213526)
8. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14:145-153. (Pubitemid 30088290)
9. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
10. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343:71-74.
11. Ullman T, Croog V, Harpaz N, et al. Progression of flat low grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125;1311-1319. (Pubitemid 37409751)
12. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030-1038.
13. Connell, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994;107:934-944. (Pubitemid 24294554)
14. Jess T, Loftus EV, Velayos FS, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006;12:669-676.
15. Ullman TA, Loftus E, Kakar S, et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol. 2002;97:922-927. (Pubitemid 34408249)
16. Rubin DT, Rothe JA, Hetzel JT, et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007;65:998-1004.
17. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385. (Pubitemid 39062279)
18. Lim CH, Dixon MF, Vail A, et al. Ten year follow up of ulcerative colitis patients with and without dysplasia. Gut. 2003;52:1127-1132. (Pubitemid 36877424)
19. Lindberg J, Stenling R, Palmquivst R, et al. Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 years' experience in a patient cohort from a defined population area. Scand J Gastroenterol. 2005;40:1076-1080. (Pubitemid 41291357)
20. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999;117:1295-300.
21. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999;117:1288-1294.
22. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658-662.